Nonmotor symptom complex of Parkinson's disease--an under-recognized entity
- PMID: 21751608
Nonmotor symptom complex of Parkinson's disease--an under-recognized entity
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disorder, after Alzheimer's disease. The cardinal clinical features of PD include asymmetric onset of bradykinesia, rigidity, and resting tremor. Most patients of idiopathic PD present with one or more of the cardinal motor features. Apart from these, various nonmotor symptoms (NMS) also occur in PD and constitute a major clinical challenge, as they are common, but often overshadowed by the dominance of motor symptoms. NMS can present at any stage of the disease including early and pre-motor phase of PD. Several NMS such as olfactory dysfunction, constipation, REM behaviour disorder, depression may antedate the motor signs, symptoms and diagnosis of PD by a number of years. Since, NMS add significantly to the overall disability caused by PD, their early recognition and treatment may go a long way in improving the quality of life of PD patients as well as the economic burden on the carers. The identification of NMS can be improved by the application of quantitative and validated instruments and scales for their assessment.
Similar articles
-
The impact and management of nonmotor symptoms of Parkinson's disease.Am J Manag Care. 2011 Oct;17 Suppl 12:S308-14. Am J Manag Care. 2011. PMID: 22087551 Review.
-
Non-motor extranigral signs and symptoms in Parkinson's disease.Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S6-12. doi: 10.1016/S1353-8020(09)70770-9. Parkinsonism Relat Disord. 2009. PMID: 20083010 Review.
-
Nonmotor manifestations of Parkinson's disease.Ann Neurol. 2008 Dec;64 Suppl 2:S65-80. doi: 10.1002/ana.21472. Ann Neurol. 2008. PMID: 19127582 Review.
-
[Non-motor disorders in Parkinson's disease].Rev Neurol. 2008 Sep 1-15;47(5):261-70. Rev Neurol. 2008. PMID: 18780273 Review. Spanish.
-
The challenge of non-motor symptoms in Parkinson's disease.Prog Brain Res. 2010;184:325-41. doi: 10.1016/S0079-6123(10)84017-8. Prog Brain Res. 2010. PMID: 20887883 Review.
Cited by
-
Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model.Brain Pathol. 2015 Jul;25(4):377-90. doi: 10.1111/bpa.12253. Epub 2015 Apr 22. Brain Pathol. 2015. PMID: 25726735 Free PMC article. Review.
-
Real-world Chinese herbal medicine for Parkinson's disease: a hospital-based retrospective analysis of electronic medical records.Front Aging Neurosci. 2024 May 2;16:1362948. doi: 10.3389/fnagi.2024.1362948. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38756536 Free PMC article.
-
Current Treatments and New, Tentative Therapies for Parkinson's Disease.Pharmaceutics. 2023 Feb 25;15(3):770. doi: 10.3390/pharmaceutics15030770. Pharmaceutics. 2023. PMID: 36986631 Free PMC article. Review.
-
Event-Related Potentials Elicited by Face and Face Pareidolia in Parkinson's Disease.Parkinsons Dis. 2020 Mar 31;2020:3107185. doi: 10.1155/2020/3107185. eCollection 2020. Parkinsons Dis. 2020. PMID: 32318259 Free PMC article.
-
Spectrum of Non-Motor Symptoms in Parkinson's Disease.Cureus. 2021 Feb 11;13(2):e13275. doi: 10.7759/cureus.13275. Cureus. 2021. PMID: 33728210 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical